Industry Leader John Maraganore, Ph.D., Joins Cybrexa Therapeutics as Strategic Advisor
25. Juni 2024 08:07 ET
|
Cybrexa Therapeutics
NEW HAVEN, Conn., June 25, 2024 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a clinical-stage oncology biotechnology company developing a novel class of tumor-targeting peptide drug conjugate (PDC)...
Cybrexa Regains Rights to CBX-12
06. Februar 2024 08:00 ET
|
Cybrexa Therapeutics
NEW HAVEN, Conn., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a clinical-stage oncology biotechnology company developing a novel class of tumor-targeting peptide drug conjugate (PDC)...
Astex Expands Drug Discovery Collaboration With MSD
08. August 2023 04:00 ET
|
Astex Pharmaceuticals
CAMBRIDGE, United Kingdom, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals (UK) (“Astex”), a pharmaceutical company dedicated to the discovery and development of novel small molecule...
Growing Emphasis on Generic Drug Manufacturing Boosts Active Pharmaceutical Ingredient Market to US$ 300.2 Billion by 2033: Persistence Market Research
25. Juli 2023 14:33 ET
|
Persistence Market Research
New York, July 25, 2023 (GLOBE NEWSWIRE) -- Worldwide revenue from the active pharmaceutical ingredients market stands at US$ 192.3 Billion in 2022, with the global market estimated to surge ahead...
Cybrexa Therapeutics To Present Data at ASCO 2023 Highlighting First-In-Human, Dose-Finding Study of Lead Candidate CBX-12
25. Mai 2023 17:01 ET
|
Cybrexa Therapeutics
Activity and Safety Profile Reinforces Potential of CBX-12 in Solid TumorsFour Objective Responses Observed in Breast and Ovarian Cancers with CBX-12Dose-Limiting Toxicity Identified as...
Cybrexa Appoints Jaya Gautam as Senior Vice President of Technical Operations
12. April 2023 08:00 ET
|
Cybrexa Therapeutics
NEW HAVEN, Conn., April 12, 2023 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a clinical-stage oncology biotechnology company developing a novel class of tumor-targeting peptide drug conjugate (PDC)...
Global Bio analytical Testing Services Market to Surpass US$ 7,749.5 Million by 2030, Says Coherent Market Insights (CMI)
24. Januar 2023 09:15 ET
|
CMI
Burlingame, Jan. 24, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global bio analytical testing services market is estimated to be valued at US$ 3,198.9 million in 2022 and is...
AI in Drug Discovery Market to Rise at 36.1% CAGR during Forecast Period: TMR Study
03. Oktober 2022 06:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – By 2031, the AI in drug discovery market size is estimated to surpass value of US$ 10.93...
Global Regenerative Medicine Market to Touch USD 167500.0 Million by 2029; Increasing Incidences of Cancer and Other Chronic Diseases to Create Opportunities for Market Growth
30. November 2021 08:56 ET
|
Research Nester
New York, Nov. 30, 2021 (GLOBE NEWSWIRE) -- According to the statistics by the American Institute of Cancer Research, the total number of new cases of cancer diagnosed worldwide in the year 2018 was...
Recro Reports Inducement Grants For New Staff
06. Oktober 2021 07:00 ET
|
Recro Pharma, Inc.
EXTON, Penn. and SAN DIEGO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex...